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Endurance athlete performance is greatly dependent on sufficient post-race system recovery, as 
endurance races have substantial physiological, immunological and metabolic effects on these 
athletes. To date, the effects of numerous recovery modalities have been investigated, however, very 
limited literature exists pertaining to metabolic recovery of athletes after endurance races without 
the utilisation of recovery modalities. As such, this investigation is aimed at identifying the metabolic 
recovery trend of athletes within 48 h after a marathon. Serum samples of 16 athletes collected 24 h 
before, immediately after, as well as 24 h and 48 h post-marathon were analysed using an untargeted 
two-dimensional gas chromatography time-of-flight mass spectrometry metabolomics approach. 
The metabolic profiles of these comparative time-points indicated a metabolic shift from the overall 
post‑marathon perturbed state back to the pre‑marathon metabolic state during the recovery period. 
Statistical analyses of the data identified 61 significantly altered metabolites including amino acids, 
fatty acids, tricarboxylic acid cycle, carbohydrates and associated intermediates. these intermediates 
recovered to pre-marathon related concentrations within 24 h post-marathon, except for xylose which 
only recovered within 48 h. Furthermore, fluctuations in cholesterol and pyrimidine intermediates 
indicated the activation of alternative recovery mechanisms. Metabolic recovery of the athletes was 
attained within 48 h post-marathon, most likely due to reduced need for fuel substrate catabolism. 
this may result in the activation of glycogenesis, uridine‑dependent nucleotide synthesis, protein 
synthesis, and the inactivation of cellular autophagy. These results may be beneficial in identifying 
more efficient, targeted recovery approaches to improve athletic performance.
Endurance races (> 5 km) have become increasingly popular over the last decade and primarily include half-
marathons (21.1 km), marathons (42.2 km), and ultra-marathons (> 42.2 km)1. Participation in these events 
requires extensive preparation including physical and mental conditioning as well as meticulously planned 
dietary strategies. According to  Barnett2, optimal athletic performance is only achieved when these principles 
are accompanied by sufficient system recovery following any endurance activity. “Recovery” comprehensively 
refers to the process in which an altered biological system, such as the metabolome, reverts to its correspond-
ing pre-perturbed  state3. In endurance athletes, metabolic recovery is thought to proceed in a biphasic manner 
with the initial phase mainly consisting of rapid oxygen, ATP and phosphocreatine replenishment, whereas the 
second phase entails the slow restoration of innate metabolism  adaptations2,3. A popular research approach for 
identifying and mapping such metabolic adaptations, quantitatively and qualitatively, is collectively referred to 
as “metabolomics”. Considering that the metabolome provides a direct depiction of the physiological state of an 
organism at a specific point in  time4, metabolomics is a formidable tool when investigating the effects of endur-
ance races on the human body, as well as the recovery thereof.
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Previous studies investigating the perturbed metabolism of endurance athletes mainly observed elevated 
concentrations of carbohydrates, fatty acids, and ketones, accompanied by reduced concentrations of amino 
 acids5. This is proposed to result from the dramatic metabolic shift between numerous fuel substrate catabolism 
systems, as well as alternative energy-producing mechanisms (α-oxidation and autophagy) activated during 
strenuous  activity6–10. Additionally, the extensive reduction in fuel substrates was associated with alterations in 
the urea cycle, purine, steroid and pyrimidine metabolism, reactive oxygen species production  pathways5,6,9–13, 
as well as the gut  microbiome9,14.
Given the nature and extent of the physiological, immunological and metabolic effects of endurance exercise 
on the human body, a substantial amount of research has been directed towards investigating various therapeutic 
recovery modalities including cryotherapy, massage, heat therapy, stretching, compression, and non-steroidal 
anti-inflammatory drugs 2,15–17, as well as the ingestion of functional foods, such as cherries, pomegranates, and 
green leafy  vegetables18. However, very limited literature is available regarding the overall recovery of the per-
turbed metabolism after an endurance race, without the ingestion and/or utilisation of recovery modalities. From 
these studies, it is evident that during the immediate hours after recovery, myocellular glycogen  restoration19,20, 
as well as phosphocreatine store replenishment and blood lactate removal takes  preference2,3,21, while lipids are 
temporarily further oxidised as an energy  source19,20. Considering this, it is suggested that glycogen restoration 
is attained within 24–48 h after endurance  exercise20, whereas amino acids, fatty acids, fatty acid-carnitine conju-
gates along with tricarboxylic acid (TCA) cycle and pyrimidine/purine pathway intermediates remain perturbed 
for at least 14 h after endurance  running5–7,9.
Considering the current lack of literature regarding the metabolic recovery of marathon athletes over an 
extended period (48 h), an untargeted two-dimensional gas chromatography time-of-flight mass spectrometry 
(GCxGC-TOFMS) serum metabolomics approach was used to investigate the unaided (without the ingestion 
and/or utilisation of recovery modalities) metabolic recovery (to baseline-related concentrations) of 16 mara-
thon athletes within 48 h post-marathon. These results might improve the current knowledge pertaining to the 
consequence of endurance activity and the time-course of recovery in the days following the event, as well as lead 
to the identification of new or additional recovery pathways and/or more targeted, perhaps even personalised, 
recovery approaches.
Results
The GCxGC-TOFMS system detected a total of 1,308 peaks of which 444 peaks were classified as “Analytes/
Unknowns”. After removing column and/or reagent-related compounds, as well as following the merging of 
duplicate peaks of compounds, such as sugars and amino acids, 839 compounds (including the 444 peaks clas-
sified as “Analytes/Unknowns” and internal standard) remained. The entire list of 838 compounds (excluding 
internal standard) was then subjected to the aforementioned processing steps [i.e. quality control coefficient of 
variation (QC-CV) filter etc.] and further statistical analyses. Considering the aim of this investigation, multiple 
group comparisons were required (Fig. 1), subsequently leading to numerous statistical outputs, which will be 
discussed below.
Multivariate statistical output. In order to visualise the overall metabolic shift over the entire time-
frame of the study, an analysis of variance (ANOVA) simultaneous component analysis (ASCA) model was 
constructed with the resulting scores graphically displayed and grouped according to the time component of the 
current study design (Fig. 2). All scripts used here are readily available in the mentioned toolboxes provided by 
Figure 1.  Schematic representation of the sample group comparisons performed during this investigation.
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Eigenvector Research Inc., with the exception of the ASCA scripts, which can be downloaded from https ://www.
bdagr oup.nl/conte nt/Downl oads/softw are/softw are.php. Based on Fig. 2, it is evident that although a marathon 
has a dramatic impact on the human serum metabolome these changes recover within 48 h, as indicated by 
the confined positioning of the 24 h and 48 h post-marathon ellipsoids relative to that of the pre-marathon. 
Furthermore, in an attempt to inspect specific adaptations between time-points, individual multi-level principal 
component analysis (ML-PCA) plots for the specified group comparisons (Fig. 1) are presented in Supplemen-
tary Fig. S1a–f. The following can be deduced from these figures (S1a–f): (1) As expected, the marathon per-
turbation (Fig. S1a) induced significant metabolic alterations, which is supported by Stander et al.10; (2) Clear 
separation (no overlap) of the recovery time-points (24 h and 48 h post-marathon) and post-marathon (day 0) 
ellipsoids (Fig. S1b and c) indicate a significant deviation from the post-marathon perturbed metabolic state; 
(3) The magnitude of metabolome variation presented 24 h and 48 h post-marathon (Fig. S1 f) seems rather 
minor as these ellipsoids appear relatively grouped (ellipsoid overlap); (4) The confined positioning of the 24 h 
and 48 h post-marathon ellipsoids relative to the pre-marathon (Fig. S1 d and e) indicate the recovery of the 
metabolome to a baseline-related state (overlapping ellipsoids). Furthermore, in order to visualise metabolite 
stratification among the comparative groups, clustering dendrograms were constructed and are included in the 
supplementary material (Fig. S3). From these figures, it is clear that stratification associations did not correlate 
with the comparative groups.
However, considering the relatively small sample set and the likelihood of increased false discovery rates 
(FDR; high dimensionality), along with controlling for model overfitting, multivariate models could not be 
validated and were therefore not used for variable selection but rather for global metabolic shift visualisation.
Univariate statistical outputs. Considering the aforementioned, variable selection was based on univari-
ate comparisons as a means of determining the specific metabolic adaptions apparent during the course of this 
investigation while controlling the FDRs and avoiding overfitting. Although repeated measures ANOVA models 
may have been appropriate, paired t-tests were preferred since the dramatic effect of the marathon would result 
in a large number of significant metabolites requiring pairwise comparisons as post-hoc tests in any event. Based 
on this, only metabolites with a Benjamini–Hochberg p value ≤ 0.05 and an effect size d-value ≥ 0.5 (moderate 
effect) in each group comparison (Fig. 1), were deemed to be statistically significant. This approach yielded a list 
of 74 metabolite markers, of which 61 were positively annotated (the remaining 13 metabolites were classified as 
“Unknowns/Analytes”) and are listed in Table 1. A more comprehensive table including average concentrations 
at each of the comparative time-points has been included in Supplementary Table S1.
Figure 2.  The ASCA plot indicating the natural, time-dependent differentiation of the comparative groups: 
pre-marathon (denoted by blue/circle), post-marathon (denoted by pink/square), 24 h post-marathon (denoted 
by turquoise/right-tilted triangle) and 48 h post-marathon (denoted with black/left-tilted triangle). The variance 
accounted for by each latent variable (LV) is indicated in parenthesis on the respective axes. The ellipsoids 
represent 95% confidence intervals of each time-points centroid.
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Compound name (PubChem ID) PM/PrM ratio D1/PM ratio D2/PM ratio D2/D1 ratio D1/PrM ratio D2/PrM ratio
Carbohydrate and associated intermediates
Arabitol (439255) 1.36* 0.75* 0.65* 0.87 1.01 0.88
Erythritol (222285) 1.77* 0.61* 0.39* 0.63 1.08 0.68
Glucose (5793) 8.91* 0.17* 0.09* 0.52 1.48 0.77
Mannitol (6251) 1.34 0.78 0.58* 0.75 1.05 0.78
Mannose (18950) 15.72* 0.11* 0.05* 0.49 1.66 0.82
Myo-inositol (440194) 1.10 0.76* 0.63* 0.82 0.84 0.69
Psicose (441036) 1.15 0.45* 0.70 1.56 0.52 0.80
Rhamnose (5460029) 0.62* 1.51 1.86* 1.23 0.94 1.16
Ribose (10975657) 1.16 0.58* 0.89 1.53 0.67 1.03
Sorbose (439192) 1.46 0.69 0.64* 0.94 1.01 0.94
Tagatose (439312) 1.87* 0.56* 0.53* 0.95 1.04 0.99
Talose (441035) 1.69* 0.57* 0.52* 0.91 0.96 0.87
Threonic acid (151152) 1.39* 0.80* 0.78* 0.98 1.11 1.09
Uridine (6029) 1.06 0.61* 1.02 1.66* 0.65 1.08
Xylose (135191) 0.90 0.52* 0.76 1.45 0.47* 0.69
Lipid and associated intermediates
α-Hydroxyoctanoic acid (94180) 1.49* 0.63* 0.67 1.06 0.94 0.99
α-Linolenic acid (5280934) 1.26* 0.69* 0.74* 1.07 0.87 0.93
β-Hydroxyhexanoic acid (11829482) 3.00* 0.38* 0.31* 0.82 1.13 0.92
5-Dodecenoic acid (5312377) 35.22* 0.02* 0.06* 3.73 0.59 2.19
10-Heptadecenoic acid (5312434) 5.87* 0.12* 0.15* 1.22 0.73 0.89
11,14-Eicosadienoic acid (5282805) 1.94* 0.54* 0.45* 0.83 1.05 0.87
11-Eicosenoic acid (5282768) 3.48* 0.31* 0.37* 1.20 1.06 1.28
Docosahexaenoic acid (445580) 1.17 0.69* 0.80 1.17 0.80 0.94
Eicosapentaenoic acid (446284) 1.30 0.69* 0.74* 1.07 0.90 0.96
Glycerol (753) 5.84* 0.17* 0.19* 1.11 0.99 1.10
Glycerol monopalmitic acid (308463) 1.87* 0.44* 0.55* 1.24 0.82 1.02
Heptadecanoic acid (10465) 1.82* 0.52* 0.52* 1.01 0.94 0.95
Lauric acid (3893) 2.07* 0.57* 0.46* 0.81 1.17 0.95
Methyl oleic acid (9922235) 1.68* 0.48* 0.72 1.51 0.81 1.22
Myristoleic acid (5281119) 12.33* 0.06* 0.08* 1.32 0.70 0.93
Oleic acid (445639) 5.04* 0.21* 0.22* 1.07 1.06 1.13
Palmitic acid (985) 1.67* 0.55* 0.57* 1.04 0.93 0.96
Palmitoleic acid (445638) 6.26* 0.19* 0.22 1.17 1.20 1.40
Pentadecanoic acid (13849) 2.21* 0.51* 0.43* 0.85 1.13 0.96
Ketones and TCA cycle intermediates
α-Ketoglutaric acid (51) 1.57* 0.58* 0.64* 1.11 0.91 1.01
β-Hydroxybutyric acid (441) 12.98* 0.06* 0.06* 1.12 0.72 0.81
Acetoacetic acid (96) 2.89 0.37* 0.19* 0.51 1.07 0.54
Citric acid (311) 1.46 0.74 0.58* 0.78 1.08 0.85
Fumaric acid (444972) 1.42 0.75 0.68* 0.91 1.06 0.96
Malic acid (525) 1.62* 0.57* 0.52* 0.90 0.93 0.84
Malonic acid (867) 1.37 0.72 0.62* 0.86 0.99 0.85
Amino acid and cholesterol-associated intermediates
α-Ethylhydracrylic acid (188979) 2.24* 0.48* 0.47* 0.97 1.08 1.05
α-Hydroxybutyric acid (11266) 2.53* 0.52* 0.49* 0.93 1.31 1.23
β-Hydroxyisobutyric acid (87) 15.39* 0.04* 0.06* 1.29 0.67 0.87
β-Hydroxyisovaleric acid (69362) 1.15 0.89 0.75* 0.84 1.02 0.86
5-Pregnen-3β,20α-diol (312224064) 1.93* 0.38* 0.36* 0.96 0.73 0.70
Alanine (5950) 0.64 2.34* 1.86* 0.79 1.51 1.19
Aminomalonic acid (100714) 0.48 2.10* 2.06* 0.98 1.01 0.99
Aspartic acid (5960) 0.60 2.03* 1.36 0.67 1.22 0.82
Glutamic acid (33032) 0.79 1.51* 1.39 0.92 1.19 1.10
Glutaric acid (743) 1.73 1.12 0.52* 0.46 1.94 0.89
Continued
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Discussion
Table 1 depicts the recovery trend of the metabolites not only initially affected by the marathon perturbation, 
but also the concentration fluctuations of additional metabolites pertinent to the 24 h and 48 h recovery period. 
In order to ascertain the metabolic recovery mechanisms following a marathon, it is imperative to first consider 
the immediate effects of a marathon on the serum metabolome of athletes, which was characterised and previ-
ously described by Stander et al.10. Briefly, alterations were mainly observed in metabolic pathways associated 
with energy production, such as elevated concentrations of various carbohydrates, TCA cycle intermediates, 
fatty acids and ketone bodies, and reduced concentrations of various amino acids and associated metabolites. 
The perturbed metabolic state may also be linked to imbalanced redox potential, the saturation of traditional 
fatty acid catabolic pathways, possible insulin secretion hampering, and the activation of cellular autophagy to 
provide additional fuel substrates.
A detailed description of the recovery (to pre-marathon related concentrations) of the identified metabolites 
are discussed in a grouped-manner, based on metabolic alterations of the recovery time-points (24 h and 48 h 
post-marathon; day 1 and day 2) relative to the perturbed metabolic state (day 0; immediately post-marathon) 
and is schematically summarised in Fig. 3.
carbohydrate metabolism. Carbohydrates, glucose in particular, are considered to be the primary fuel 
substrates used by the body during physical activity. Stander et al.10 and Lewis et al.6 reported severely elevated 
serum concentrations of various carbohydrates immediately after a marathon (day  0). In this metabolomics 
investigation, it is clear that the majority of the serum carbohydrates (glucose and mannose) and associated 
metabolites (uridine, ribose, glycerol, and myo-inositol) returned to baseline (pre-marathon) concentrations 
within 24 h post-marathon (Table 1), with the exception of xylose (also dietary-related). This can be ascribed to 
the restoration of the glycogen stores, which were perceived as "depleted" in the initial stages of the  marathon10.
Moreover, substantial reductions in uridine concentrations were observed within 24 h post-marathon 
(Table 1). Uridine is a nucleoside formed via the conjugation product of ribose and uracil and is a key component 
in RNA and subsequently protein  synthesis22. This, in conjunction with the reduced ribose, indicated possible 
increased nucleotide production via the activation of the pyrimidine salvation metabolism. The pyrimidine sal-
vation metabolism refers to the adaptive mechanism by which nucleotides can be synthesised using pre-formed 
nucleosides and nucleobases, usually following a nucleotide degradation  period5,22, such as the extensive protein 
catabolism induced by a  marathon6,7,10. These recycled nucleotides can also interact with lipids to form pyrimi-
dine nucleotide–lipid conjugates, a key component in cell membrane  structures22. Considering this, the slight 
reduction in uridine concentrations observed 24 h after the completion of the marathon, may also be associated 
with the restoration of damaged cellular membranes, which occur as a result of strenuous  exercise10. This is 
further substantiated by the reduction/recovery of myo-inositol concentrations within 24 h post-marathon, as 
it is a well-known constituent of  glycerophospholipids23.
Additionally, the de novo pyrimidine synthesis pathway is dependent on various elements of the pentose 
phosphate  pathway22, particularly ribose-5-phosphate and phosphoribosyl  pyrophosphate24. Since these are 
interlinking substrates for the production of erythrose-4-phosphate24, the recovery of erythritol (produced from 
the latter)25 not only suggests the activation of glycogenesis via the utilisation of pentose phosphate pathway 
intermediates, but further supports the activation of the abovementioned nucleotide repair mechanisms. Fur-
thermore, since the majority of the erythritol is absorbed rather than  metabolized26, as well as the fact that it is a 
well-known alternative sugar added to low-calorie  foods27 frequently ingested by athletes, the alterations of this 
metabolite 24 h and 48 h post-marathon may also be due to reduced ingestion of such foods by the athletes dur-
ing the recovery period. Similarly, several of the metabolites in Table 1, including mannitol, psicose,  sorbose27,28, 
 tagatose29, and  xylose24, are natural constituents of fruit and vegetables, Food and Drug Administration approved 
alternative bulk sweeteners, and/or the products of metabolised sweeteners such as threonic  acid30, and arabi-
tol via  arabinose31. Considering that endurance races reportedly alter gut microbiome composition, as well as 
increase intestinal permeability resulting in gut microbiome (GM) metabolite  migration32, reductions in several 
Table 1.  Ratio of concentration fluctuations in the serum metabolite markers (n = 61) best describing the 
detected variation and metabolic recovery of the athletes within 48 h post-marathon. PrM Pre-marathon, PM 
Post-marathon, D1 24 h post-marathon, D2 48 h post-marathon. Significant p-and d-values (*).
Compound name (PubChem ID) PM/PrM ratio D1/PM ratio D2/PM ratio D2/D1 ratio D1/PrM ratio D2/PrM ratio
Glycine (750) 0.59 1.79* 1.45 0.81 1.06 0.86
Hydroxyproline (5810) 0.44 2.03 2.68* 1.32 0.89 1.18
Methionine (6137) 0.54 2.17* 1.88* 0.87 1.18 1.02
Phenylalanine (6140) 0.64 1.93* 1.47* 0.76 1.24 0.95
p-Hydroxyphenylacetic acid (127) 2.00 0.51* 0.45* 0.88 1.03 0.90
p-Hydroxyphenyllactic acid (9378) 1.53 0.66* 0.58* 0.88 1.01 0.89
Pyroglutamic acid (7405) 0.71* 1.35* 1.41* 1.04 0.95 1.00
Squalene (638072) 3.39* 0.31* 0.34* 1.07 1.06 1.14
Tyrosine (6057) 0.64 1.78* 1.57* 0.88 1.14 1.01
Valine (6287) 0.53 1.83 2.21* 1.21 0.97 1.18
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of the detected metabolite markers (Table 1)31,33 could also be ascribed to the restoration of GM homeostasis and 
a reduction in host substrate availability/dietary ingestion.
Lipid metabolism. The aforementioned depletion of intracellular glucose and glycogen stores results in 
extensive lipolysis of triacylglycerols in adipose tissue, skeletal muscle and the liver during strenuous  activity5,10,34. 
Reduced lipolysis intermediate (α-linolenic acid, 11,14-eicosadienoic acid, 11-eicosenoic acid, 5-dodecenoic 
acid, docosahexaenoic acid, eicosapentaenoic acid, lauric acid, myristoleic acid, oleic acid, palmitic acid, palmi-
toleic acid, glycerol, and glycerol monopalmitic acid) concentrations were observed within 24 h post-marathon 
(Table 1) and coincided with similar findings from previous  literature5–7. The normalisation of these is a clear 
attestation of the down-regulation of  lipolysis7 mainly due to the aforementioned restoration of the glycaemic 
flux, concurrent with reduced ATP requirements during passive  recovery34,35. The initial rapid reduction in 
serum fatty acids within 24 h post-marathon followed by a slight increase after 48 h post-marathon (Table 1) 
suggests a temporary upregulation of fatty acid oxidation, succeeded by a short period of fatty acid re-esteri-
fication7,36,37. According to Egan and  Zierath20, myocellular glycogen replenishment is preferentially activated 
during the first 24–48 h post-exercise, subsequently causing a temporary increase in fat oxidation during this 
time, thus substantiating the aforementioned. Withal, normalised concentrations of β-hydroxyhexanoic acid (a 
β-oxidation intermediate) within the 24 h post-marathon recovery period indicates the restoration of the previ-
ously mentioned β-oxidation and redox  imbalances10,38, subsequently eliminating the need for alternative fatty 
acid catabolism pathways, such as α-oxidation, which was previously proposed to be up-regulated during stren-
uous  exercise10. This hypothesis is further supported by a reduction in α-hydroxyoctanoic acid (an α-oxidation 
intermediate) and the odd-chain fatty acids (OCFAs; tridecanoic acid, pentadecanoic acid, heptadecanoic acid, 
and 10-heptadecenoic acid). However, it should be noted that reductions in OCFAs, as well as some of the afore-
mentioned even-chain fatty acids, may also be ascribed to alleviated  autophagy39, reduced dietary ingestion of 
these, and an altered microbial  activity40.
Ketone production and the tcA cycle. The apparent reduced need for ATP post-marathon35 and the 
subsequently reduced fuel substrate catabolism during passive recovery is anticipated to cause a reduction in 
both acetyl-CoA and malonyl-CoA  synthesis34. The recovery of the malonic acid concentrations within 24 h 
post-marathon not only substantiates the latter as it coincides with the previously mentioned transient increase 
in long-chain fatty acid oxidation, but could also be an indication of said elevated fatty acid synthesis. Further-
more, the restored concentrations of TCA cycle intermediates (α-ketoglutaric acid, fumaric acid, citric acid, and 
malic acid) and ketones (acetoacetic acid and β-hydroxybutyric acid) to pre-marathon concentrations within 
Figure 3.  A metabolic chart summarising the major pathways affected during and after a marathon 
perturbation. Microbial interactions are denoted with bold dashed arrows and the line-graphs schematically 
illustrate the time-dependant concentration shifts of the significantly altered metabolites. CoA coenzyme A, 
CO2 carbon dioxide, CTP cytidine triphosphate, FAD+ flavin adenine dinucleotide, FADH2 flavin adenine 
dinucleotide + hydrogen, GDP guanosine diphosphate, GTP guanosine triphosphate, NAD+ nicotinamide 
adenine dinucleotide, NADH nicotinamide adenine dinucleotide + hydrogen, Pi inorganic phosphate, TCA 
tricarboxylic acid, RNA ribonucleic acid, UDP uridine diphosphate, UMP uridine monophosphate, UTP uridine 
triphosphate (adapted from Stander et al.10).
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24 h after the marathon (Table 1), support the aforementioned glycaemic flux recovery. This concurs with Nie-
man et al.7, who reported that these pathways remain perturbated for approximately 14 h post-exercise. Addi-
tionally, reduced concentrations of ketones, particularly β-hydroxybutyric acid, support the restoration of the 
previously mentioned redox  imbalance10,38 and suggest an enhanced metabolic clearance  rate41 in athletes within 
24 h post-marathon. β-Hydroxybutyric acid is also a signalling molecule serving as a regulator of gene expres-
sion and adaptive responses via the inhibition of class I histone deacetylases, rendering this metabolite invalu-
able to the recovery  process41.
Amino acid metabolism. In accordance with the carbohydrates and lipids profile, various amino acids 
(alanine, aspartic acid, glycine, glutamic acid, methionine, phenylalanine, and tyrosine) and associated metabo-
lites (glutaric acid, p-hydroxyphenylacetic acid, p-hydroxyphenyllactic acid, pyroglutamic acid, and hydroxypro-
line) recovered to baseline concentrations within 24 h after the completion of the marathon (Table 1), indicating 
a reduced need for amino acid catabolism during this recovery phase. However, the slight reductions in these 
amino acids that occur between 24 and 48 h of recovery could be an indication of protein synthesis, as sub-
stantiated by the aforementioned uridine/ribose profile (Table 1). Contrarily, slight elevations in recovery time-
point hydroxyproline may be indicative of delayed post-marathon collagen catabolism, thus supporting previ-
ous  literature42. Furthermore, the reduced concentrations of α-hydroxybutyric acid (a threonine/methionine 
metabolism intermediate) within 24 h post-marathon compared to the elevated post-marathon (Day 0) profile 
correlates with reduced amino acid catabolism and further suggests recovery of previously reported transiently 
hampered insulin  secretion10, glucose absorption, and imbalance redox  potential43.
In addition to the proteinogenic amino acids, elevated concentrations of the branched-chain amino acid 
(BCAA) valine, in conjunction with reduced BCAA-associated catabolism intermediates (Table 1) such as 
β-hydroxyisobutyric acid (valine metabolism), α-ethylhydracrylic acid (allo-isoleucine metabolism), and 
β-hydroxyisovaleric acid (leucine metabolism), are indicative of a reduction in BCAA catabolism. BCAAs 
are reportedly one of the major factors regulating mammalian target of rapamycin complex 1 (mTOR1), a 
multi-protein complex responsible for the activation of numerous biological processes imperative to metabolic 
recovery, including cell proliferation, gene expression for lipid and protein synthesis, as well as the inhibition 
of cellular  autophagy44. The proposed activation of these recovery mechanisms is further substantiated by the 
aforementioned uridine/ribose profile (Table 1), as well as the reduction in various cell membrane-associated 
intermediates, such as fatty acids (particularly OCFAs), myo-inositol and cholesterol intermediates (squalene and 
5-pregnen-3β,20α-diol) observed within 24 h post-marathon. Reduced concentrations of cholesterol intermedi-
ates within 24 h after the marathon in comparison to the post-marathon (day 0) concentrations also suggest inac-
tivation of  steroidogenesis45, which was previously proposed to be induced as a result of endurance  activity10,37.
Aminomalonic acid was also observed to recover to pre-marathon concentrations within 24 h post-marathon. 
Although this metabolite has been associated with oxidative damage to protein/amino acid  residues46, it has 
also been isolated from Escherichia coli47. As such, its precise mechanism of action pertaining to the metabolic 
recovery process remains to be elucidated.
conclusion
The results of this investigation suggest that the serum metabolome of athletes largely recovers to baseline (pre-
marathon) status within 24 h, with total recovery evident within 48 h post-marathon without the intervention 
of recovery aids. This can be ascribed to a reduction in ATP requirements during passive recovery, which in turn 
allows for the activation of anabolic recovery mechanisms or pathways. The possible cascade of events resulting 
in total metabolome recovery within 24/48 h post-marathon are: (a) reduced energy requirements promoting 
the restoration of the imbalanced redox potential and intracellular glycaemic flux, thus stimulating glycogenesis. 
(b) In turn, this further reduces the need for alternative fuel substrate catabolism (of lipids and amino acids) 
and ketogenesis, (c) activating additional cellular repair mechanisms such as the uridine-dependent nucleotide 
salvage pathway, mTOR1 stimulation (subsequently inactivating cellular autophagy), as well as possible protein 
and lipid synthesis/fatty acid re-esterification. Moreover, GM-associated markers emphasize the close metabolic 
interaction between man and microbe.
Limitations and future prospects
Possible limitations of this investigation may include the inevitable confounder of human genotype/phenotype 
(sex, age and ethnicity) variation, as well as individual athlete dietary variation. Although the athletes’ dietary 
intake was recorded throughout the investigation, adding dietary restrictions to the already refrained use of 
recovery aids would be considered too much of an interference to the personalised regimens of these athletes. 
However, in an attempt to circumvent the variability in participant demographics (age, sex, fitness, running 
experience, etc.), the study design included repeated measures of the same individuals and the use of statistical 
methods that consider the dependence between observations (therefore each participant becomes their own 
control)48,49. Nevertheless, such individual variation allows for a higher level of robustness in the results, which 
provides a better representation of the true nature of the activated recovery mechanisms as the body attempts 
to reach homeostasis.
Although the current investigation provided a holistic (untargeted) representation of the metabolome recov-
ery after a marathon, future studies may consider applying more targeted approaches based on these results 
to possibly identify more personalised/efficient recovery modalities. Additionally, since this investigation was 
performed on a relatively small cohort, future investigations consisting of larger cohorts and/or serum samples 
obtained at additional time-points (e.g. 12 h, 36 h, and 72 h post-marathon) are required to validate these find-
ings, ultimately allowing for better metabolic mapping of the in-between stages via the identification of additional 
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metabolite markers pertinent to the metabolic recovery trend of endurance athletes. Considering that metabolic 
differences correlating with gender heterogeneity could not be positively annotated due to limited cohort size, 
future studies may consider including larger gender-specific cohorts. Lastly, since GM metabolism seems to be an 
integral part of athletic performance, more targeted analysis of the associated metabolites or using an alternative 
biological medium (such as faecal matter, urine, etc.) could provide a more perspicuous understanding of the 
importance of the GM in terms of metabolome recovery.
Methods and materials
participants and the marathon race. The participants (n = 16; 10 males and 6 females) were selected at 
random from the pool of athletes competing in the Druridge Bay Marathon in Newcastle (UK). The eligibility 
of the selected participants was assessed by means of a health and dietary questionnaire, after which those indi-
viduals with food allergies, cardiovascular complications, musculoskeletal disorders/injuries, or those receiving 
anti-inflammatory treatment were excluded from the study. In addition, female participants completed a men-
struation cycle questionnaire. Considering the ethical implications concerning ethnicity classifications of par-
ticipants when it is not central to the research topic, as well as the fact that this study was not biased towards any 
ethnic groups, nor were any of the aims a comparison of ethnicity with respect to the marathon induced changes 
to the human metabolome, athlete ethnicity was not recorded. All athletes were instructed to abstain from using 
any recovery modalities/therapies such as cryotherapy, pressure garments, foam rolling, active recovery (moder-
ate exercise bouts), NSAID, vitamins, etc. during the recovery period of this investigation. A summary of par-
ticipant characteristics is presented in Table 2, while a summary of age, sex, and overall performance distribution 
of the athletes are presented in Table S2 (Supplementary information). The Druridge marathon entails running 
four laps around the Country Park (Northumberland coast, UK), which mainly consists of grassy, concrete 
mixed terrain. Approximately 1.6 km of each lap consists of soft sand (± 6.4 km)50 and may contribute to slower 
finishing times (Table 2).
Sample collection. This investigation forms part of a larger, double-blinded placebo study (Supplementary 
Fig. S2), in which 31 athletes participating in the 2016 Druridge Bay Marathon either received multiple beetroot 
(n = 15 athletes) or placebo (n = 16 athletes) supplements, over a period of 48 h. Blood samples (n = 124 samples) 
were collected 24 h before (as a fasting, yet hydrated, baseline/pre-marathon), immediately after (within 30 min; 
post-marathon [day 0]), as well as 24 h (day 1 post-marathon) and 48 h (day 2 post-marathon) post-marathon by 
means of antecubital (basilica vein)  venepuncture10,50. Venous sampling was limited to only four sampling inter-
vals considering the impact and inconvenience of increased blood sampling, which would have led to increased 
participant drop-out. These samples were procured from the Faculty of Health and Life Sciences, Department 
of Sport, Exercise and Rehabilitation at Northumbria University in Newcastle upon Tyne (UK), and transported 
to the Laboratory of Infectious and Acquired Diseases, Focus Area: Human Metabolomics at the North-West 
University in Potchefstroom, as previously described by Stander et  al.10. Considering the aim of the current 
investigation, only the serum samples (n = 64) of the 16 athletes that ingested placebo supplements were included 
in this study. Furthermore, since this study only focuses on the metabolic adaptations presented during a 48 h 
recovery period, information regarding additional clinical serum measurements are not included, but are avail-
able in a complementary physiological publication based on the same  cohort50.
Sample extraction and derivatisation. As previously described in detail by Stander et al.10, all samples 
along with pooled quality control (QC) samples (pooled 50 μL of each sample) were subjected to a total metabo-
lome extraction. As part of this process, smaller aliquots of the samples (50 μL) were prepared, before adding 
50 μL of the internal standard (3-phenylbutyric acid; 0.45 μg/mL) dissolved in a chloroform:methanol:water 
(1:3:1) solution. The latter serves as a metabolite conservation step to ensure that larger polar and non-polar 
compounds and associated metabolites (e.g. amino acids, fatty acids, purines, pyrimidines, alkenes, alkanes etc.) 
can be analysed using the GCxGC-TOFMS. Protein precipitation of the samples commenced by adding 300 μL 
of ice-cold acetonitrile, where after each vial was subjected to a 2  min mixing step (REAX D-91126 vortex; 
Heidolph Instruments GmbH & Co.KG, Schwabach, Germany) and 10 min centrifugation at 4,000 rpm. The 
supernatants were extracted, transferred to a clean GC–MS vial, and dried with a light stream of nitrogen gas 
for 45 min, whilst being housed in a heating block set at 40 °C. Once the solvent evaporated, 25 μL of methox-
amine hydrochloride dissolved in pyridine (15 mg/mL) was added to each sample and incubated for 90 min at 
Table 2.  Participant demographical information and endurance race experience history.
Participant demographical information Average ± standard deviation
Age (years) 39 ± 12
Pre-marathon athlete weight (kg) 72.2 ± 11.9
Post-marathon athlete weight (kg) 70.8 ± 11.7
Running experience (years) 8 ± 7
Marathon experience (races) 21 ± 40
Finishing time (hh:mm:ss) 04:30:25 ± 00:36:48
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50 °C. Lastly, 40 μL of BSTFA enriched with 1% TCMS was added, and samples were left to derivatise/silylate for 
60 min at 60 °C. Derivatised samples were then transferred to a clean glass GC–MS vial containing a vial insert.
GcxGc‑tofMS analysis. Samples were injected into the Pegasus 4D GCxGC-TOFMS analytical appara-
tus (LECO Africa (Pty) Ltd, Johannesburg, South Africa) in a randomised order by using a Gerstel 104 auto-
sampler tray (GmbH and co. KG, Mülheim van der Ruhr, Germany), with QC samples preceding approximately 
every 7th sample for quality assurance purposes. Each sample (1 μL) was injected using a 1:3 split ratio with a 
constant injector temperature of 270 °C and a carrier gas (purified helium) flow rate of 1 mL/min. The primary 
oven containing a Restek Rxi-5MS capillary column (30 m; 0.25 μm diameter and 0.25 μm film thickness) was 
set to operate at an initial temperature of 70 °C before incrementally (4 °C/min) increasing to a final tempera-
ture of 300 °C (maintained for 2 min). In addition, the secondary oven, fitted with a Restek Rxi-17 capillary 
column (1 m; 0.25 μm diameter and 0.25 μm film thickness), was programmed with an initial temperature of 
85 °C which was set to incrementally increase with 4.5 °C/min until a final temperature of 300 °C was reached. 
The thermal modulator, amid the two columns, was set to intermittently pulse streams of hot and cold nitrogen 
gas for approximately 0.5 s (every 3 s). Mass spectra (ms) of ions (50–800 m/z range) was acquired at a rate of 
200 ms/s, while the ms of the first 400 s of the run was discarded to exclude extraction solvent elution. How-
ever, the latter was not removed from the time axis of the primary column to ensure compound retention time 
validity. The transfer line and ion source were set to function at 270 °C and 220 °C, respectively, with a detector 
voltage of 1,600 V and ion filament bias of − 70e V. After analytical analysis, the data generated was processed 
using the ChromaTOF software version 4.7.1 (LECO Corporation), which included ms deconvolution, peak 
alignment and peak annotation via mass fragment pattern and retention time comparison with in-house librar-
ies compiled from previously injected  standards51. ChromaTof parameter settings included peak widths of 9 and 
0.2 for the 1st and 2nd dimension respectively, and a signal-to-noise ratio of 100, with a maximum of 100,000 
unknown peaks allowed (to remove bias). All metabolites with molecular masses between 50 and 800 Da were 
detected with a minimum of 70% similarity match to the in-house libraries for identification. The experimental 
procedure performed was in accordance with proposed guidelines and regulations, as approved by the North-
West University (South Africa) and forms part of the laboratory’s standard operating procedures (SOP number: 
HM-MET-056).
Statistical analysis and group comparison. Prior to data analysis, pooled QC samples were compared 
to ensure data validity before interpretation. Data analyses commenced with compound normalisation in rela-
tion to an internal standard and all identified analytical contaminants/plasticizers/column related metabolites 
were removed. The data was then subjected to numerous data clean-up steps, including a QC-CV filter (retaining 
metabolites with CV ≤ 30), QC drift/batch correction (using a pooled QC sample), zero-value replacement (with 
random, small values along the tail distribution of the data), 50% zero value filter, log transformation and auto-
scaling48,52–54. Hereafter the data was subjected to a multi-statistical approach consisting of two main objectives 
i.e. (1) obtain a global pattern of the metabolic profile of athletes over time and to some extent validate the design 
against the logical result, as well as (2) determine specific metabolic adaptations between time-points (Fig. 1) to 
distinguish between sources of variation due to early (day 1 vs day 0) and late (day 2 vs day 0) stages recovery; 
from full recovery (day 2 vs pre-marathon). As such, statistical analyses consisted of both paired univariate and 
multivariate approaches, using  MATLAB55 with a PLS  toolbox56. In terms of the multivariate analyses, an ML-
PCA were used to inspect specific time-point differences in the multivariate space, whereas and an ASCA was 
employed to summarise the overall metabolic perturbation observed over the entire timeframe of the  study57. 
Both these methods take the dependence between observations into account. Furthermore, univariate data 
analyses included a paired t-test, corrected for multiple testing by controlling the FDR (limiting to 5%) using 
the Benjamini–Hochberg  procedure58, and a dependent effect size test to respectively assess the statistical and 
practical significance of each  metabolite48.
Considering the inevitable confounder of inter-individual variation, a repeated measures statistical design was 
employed to control for the latter as each athlete’s metabolic variation is evaluated relative to him/herself. That 
said, statistical approaches for paired data may not correct for all confounders and as such this design aimed to 
ensure equal representation across different confounders as indicated in Table S2 (Supplementary information). 
Although more complex models were considered for variable selection (i.e. repeated measures ANOVA), these 
models would not be applicable due to the small sample size and were therefore excluded.
ethical approval. Ethical approval for this investigation, conducted according to the Declaration of Hel-
sinki and International Conference on Harmonization Guidelines, was obtained from the Research Ethics Com-
mittee of the Faculty of Health and Life Sciences at the Northumbria University in Newcastle upon Tyne, UK 
(reference number: HLSTC120716). Informed, written consent was obtained from all individuals included in 
the study.
Data availability
As the current investigation is part of a larger collaboration study consisting of multiple aims, the dataset of 
this investigation is not yet publicly available but can be acquired from the corresponding author on reasonable 
request. The authors declare that all the results included in this study have been presented clearly, honestly and 
without fabrication, falsification, or inappropriate data manipulation.
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